留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

线粒体靶向抗氧化剂研究进展

樊鹏程 葛越 蒋炜 景临林 马慧萍 贾正平

樊鹏程, 葛越, 蒋炜, 景临林, 马慧萍, 贾正平. 线粒体靶向抗氧化剂研究进展[J]. 药学实践与服务, 2015, 33(1): 1-4,8. doi: 10.3969/j.issn.1006-0111.2015.01.001
引用本文: 樊鹏程, 葛越, 蒋炜, 景临林, 马慧萍, 贾正平. 线粒体靶向抗氧化剂研究进展[J]. 药学实践与服务, 2015, 33(1): 1-4,8. doi: 10.3969/j.issn.1006-0111.2015.01.001
FAN Pengcheng, GE Yue, Jiang Wei, JING Linlin, MA Huiping, JIA Zhengping. Research progress in mitochondria-targeted antioxidants[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 1-4,8. doi: 10.3969/j.issn.1006-0111.2015.01.001
Citation: FAN Pengcheng, GE Yue, Jiang Wei, JING Linlin, MA Huiping, JIA Zhengping. Research progress in mitochondria-targeted antioxidants[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 1-4,8. doi: 10.3969/j.issn.1006-0111.2015.01.001

线粒体靶向抗氧化剂研究进展

doi: 10.3969/j.issn.1006-0111.2015.01.001
基金项目: 国家自然科学基金资助项目(81202458);全军医药卫生科研项目(CLZ12JB06)

Research progress in mitochondria-targeted antioxidants

  • 摘要: 线粒体是细胞呼吸的主要场所,在细胞的生命周期中扮演重要角色,三羧酸循环和氧化磷酸化都是在线粒体中进行。线粒体功能障碍可导致一系列疾病,如缺血-再灌注损伤、败血症和糖尿病等。线粒体是神经退行性病变的治疗靶点,也是药物转运策略研究的引人注目的靶位。虽然线粒体所介导的疾病进程的分子机制尚未完全阐明,但氧化应激是关键的环节。开发线粒体靶向的抗氧化应激保护药物具有诱人的前景。线粒体靶向抗氧化剂是指以线粒体为作用靶位的具有抗氧化作用的药物。该文介绍了现有的线粒体靶向抗氧化剂的概念、分类及其疾病治疗研究进展。
  • [1] Jordan J,de Groot PW,Galindo MF.Mitochondria:the headquarters in ischemia-induced neuronal death[J].Cent Nerv Syst Agents Med Chem,2011,11:98-106.
    [2] Finkel T.Radical medicine:treating ageing to cure disease[J].Nat Rev Mol Cell Biol,2005,6:971-976.
    [3] Fantinelli JC,Perez Nunez IA,Gonzalez Arbelaez LF,et al.Participation of mitochondrial permeability transition pore in the effects of ischemic preconditioning in hypertrophied hearts:role of NO and mitoK(ATP)[J].Int J Cardiol,2011,166:173-180.
    [4] Larsen GA,Skjellegrind HK,Berg-Johnsen J,et al.Depolarization of mitochondria in isolated CA1 neurons during hypoxia,glucose deprivation and glutamate excitotoxicity[J].Brain Res,2006,1077:153-160.
    [5] Lee DR,Helps SC,Macardle PJ,et al.Alterations in membrane potential in mitochondria isolated from brain subregions during focal cerebral ischemia and early reperfusion:evaluation using flow cytometry[J].Neurochem Res,2009,34:1857-1866.
    [6] Dave KR,Bhattacharya SK,Saul I,et al.Activation of protein kinase C delta following cerebral ischemia leads to release of cytochrome C from the mitochondria via bad pathway[J].PLoS One,2011,6(7):e22057.
    [7] Moreira PI,Zhu X,Wang X,et al.Mitochondria:a therapeutic target in neurodegeneration[J].Biochim Biophys Acta,2010,1802:212-220.
    [8] Diogo CV,Grattagliano I,Oliveira PJ,et al.Re-wiring the circuit:mitochondria as a pharmacological target in liver disease[J].Curr Med Chem,2011,18:5448-5465.
    [9] Walters AM,Porter GAJ,Brookes PS.Mitochondria as a drug target in ischemic heart disease and cardiomyopathy[J].Circ Res,2012,111:1222-1236.
    [10] Reale M,Pesce M,Priyadarshini M,et al.Mitochondria as an easy target to oxidative stress events in Parkinson's disease[J].CNS Neurol Disord Drug Targets,2012,11:430-438.
    [11] Gruber J,Fong S,Chen CB,et al.Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing[J].Biotechnol Adv,2012,31:563-592.
    [12] Mukhopadhyay P,Horvath B,Zsengeller Z,et al.Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion:therapeutic potential of mitochondrially targeted antioxidants[J].Free Radic Biol Med,2012,53:1123-1138.
    [13] Telford JE,Kilbride SM,Davey GP.Decylubiquinone increases mitochondrial function in synaptosomes[J].J Biol Chem,2010,285:8639-8645.
    [14] Coulter CV,Kelso GF,Lin TK,et al.Mitochondrially targeted antioxidants and thiol reagents[J].Free Radic Biol Med,2000,28:1547-1554.
    [15] Modica-Napolitano JS,Aprille JR.Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells[J].Adv Drug Deliv Rev,2001,49:63-70.
    [16] Sheu SS,Nauduri D,Anders MW.Targeting antioxidants to mitochondria:a new therapeutic direction[J].Biochim Biophys Acta,2006,1762:256-265.
    [17] Skulachev VP.Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases[J].J Alzheimers Dis,2012,28:283-289.
    [18] Smith RA,Porteous CM,Coulter CV,et al.Selective targeting of an antioxidant to mitochondria[J].Eur J Biochem,1999,263:709-716.
    [19] Hughes G,Murphy MP,Ledgerwood EC.Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factor-induced apoptosis:evidence from mitochondria-targeted antioxidants[J].Biochem J,2005,389:83-89.
    [20] Kelso GF,Porteous CM,Coulter CV,et al.Selective targeting of a redox-active ubiquinone to mitochondria within cells:antioxidant and antiapoptotic properties[J].J Biol Chem,2001,276:4588-4596.
    [21] Solesio ME,Prime TA,Logan A,et al.The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease[J].Biochim Biophys Acta,2013,1832:174-182.
    [22] Asin-Cayuela J,Manas AR,James AM,et al.Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant[J].FEBS Lett,2004,571:9-16.
    [23] Rodriguez-Cuenca S,Cocheme HM,Logan A,et al.Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice[J].Free Radic Biol Med,2010,48:161-172.
    [24] Zelber-Sagi S,Lurie Y,Nitzan-Kaluski D,et al.Mitochondria-targeted antioxidants prevent liver injury in animal models of steatohepatitis and CCl4 intoxication[J].Alcoholic Liver Dis,2006,S267.
    [25] Lowes DA,Thottakam BM,Webster NR,et al.The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis[J].Free Radic Biol Med,2008,45:1559-1565.
    [26] Ghosh A,Chandran K,Kalivendi SV,et al.Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model[J].Free Radic Biol Med,2010,49:1674-1684.
    [27] Vergeade A,Mulder P,Vendeville-Dehaudt C,et al.Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction:prevention by the targeted antioxidant MitoQ[J].Free Radic Biol Med,2010,49:748-756.
    [28] Wani WY,Gudup S,Sunkaria A,et al.Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain[J].Neuropharmacology,2011,61:1193-1201.
    [29] Zhao K,Zhao GM,Wu D,et al.Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling,oxidative cell death,and reperfusion injury[J].J Biol Chem,2004,279:34682-34690.
    [30] Wright JS,Carpenter DJ,McKay DJ,et al.Theoretical calculation of substituent effects on the O-H bond strength of phenolic antioxidants related to vitamin E[J].J Am Chem Soc,1997,119:4245-4252.
    [31] Schiller PW,Nguyen TM,Berezowska I,et al.Synthesis and in vitro opioid activity profiles of DALDA analogues[J].Eur J Med Chem,2000,35:895-901.
    [32] 赵善民,何显教,晋 玲,等.急性低氧对家兔血压心率微血管反应性及自由基的影响[J].中国应用生理学杂志,2003,19:341-344.
    [33] Chen Z,Putt DA,Lash LH.Enrichment and functional reconstitution of glutathione transport activity from rabbit kidney mitochondria:further evidence for the role of the dicarboxylate and 2-oxoglutarate carriers in mitochondrial glutathione transport [J].Arch Biochem Biophys,2000,373:193-202.
  • [1] 赖立勇, 夏天爽, 徐圣焱, 蒋益萍, 岳小强, 辛海量.  中药青蒿抗氧化活性的谱效关系研究 . 药学实践与服务, 2024, 42(): 1-9. doi: 10.12206/j.issn.2097-2024.202211012
    [2] 陈金涛, 许玲, 章祎俊, 郑月娟, 何宗阳, 刘良善, 马明华, 张若曦, 王振伟, 年华.  基于网络药理学、分子对接研究金芪清疏颗粒治疗CAP的潜在机制 . 药学实践与服务, 2024, 42(): 1-9. doi: 10.12206/j.issn.2097-2024.202312014
    [3] 徐卫凡, 徐武牧, 丁卢颖, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸防治D-半乳糖损伤成骨细胞骨丢失的作用及机制研究 . 药学实践与服务, 2023, 41(3): 155-159. doi: 10.12206/j.issn.2097-2024.202202030
    [4] 王道鑫, 张添光, 缪朝玉.  血管内皮细胞线粒体氧化应激与动脉粥样硬化 . 药学实践与服务, 2023, 41(6): 329-334, 392. doi: 10.12206/j.issn.2097-2024.202205116
    [5] 石志群, 高迎春, 张冬梅, 陈克明, 景临林, 马慧萍.  7-羟乙基白杨素对高原脑水肿的作用机制初探 . 药学实践与服务, 2022, 40(5): 399-402, 415. doi: 10.12206/j.issn.2097-2024.202205090
    [6] 王玮婷, 殷雪琴, 夏金娥, 张夏炎.  五味子乙素通过ROS介导内质网应激诱导人乳腺癌MDA-MB-231细胞凋亡的研究 . 药学实践与服务, 2021, 39(6): 499-503, 533. doi: 10.12206/j.issn.1006-0111.202106123
    [7] 钱珺, 谢凡, 卫克昭, 高建平, 李文艳.  复方滋阴颗粒对去卵巢大鼠性激素和氧化应激水平的影响 . 药学实践与服务, 2020, 38(5): 431-434. doi: 10.12206/j.issn.1006-0111.201912023
    [8] 刘景雪, 黄瑾.  改善糖尿病内皮祖细胞功能的研究进展 . 药学实践与服务, 2020, 38(1): 18-21. doi: 10.3969/j.issn.1006-0111.201906065
    [9] 陈静, 陈明珠, 黄玉香, 程晶, 黄雅平.  绿萼梅总黄酮对慢性温和刺激所致抑郁大鼠神经内分泌和氧化应激的影响 . 药学实践与服务, 2019, 37(3): 226-230. doi: 10.3969/j.issn.1006-0111.2019.03.007
    [10] 赵安鹏, 靳婷, 王荣.  槟榔醇提物对H9C2心肌细胞的抗缺氧保护作用 . 药学实践与服务, 2019, 37(4): 294-298. doi: 10.3969/j.issn.1006-0111.2019.04.002
    [11] 朱玉婷, 王谨慧, 李茂星, 李晓琳, 陶文迪, 刘延彤.  毛蕊花苷对高原缺氧小鼠记忆损伤的改善及机制研究 . 药学实践与服务, 2019, 37(1): 23-26. doi: 10.3969/j.issn.1006-0111.2019.01.006
    [12] 武柠子, 马慧萍, 王昕, 何蕾, 景临林, 贾正平.  模拟高原缺氧环境对大鼠心、脑组织损伤的研究 . 药学实践与服务, 2018, 36(3): 250-254. doi: 10.3969/j.issn.1006-0111.2018.03.013
    [13] 谢华, 王延玲, 王昌, 李文斌, 贾正平, 王荣.  美托洛尔对急进海拔3400 m大鼠的心肌保护作用研究 . 药学实践与服务, 2018, 36(3): 238-242. doi: 10.3969/j.issn.1006-0111.2018.03.010
    [14] 沈启睿, 李永华, 张文杰, 王培.  同型半胱氨酸激活JNK信号通路诱导血管平滑肌细胞氧化应激的损伤研究 . 药学实践与服务, 2018, 36(6): 499-502,511. doi: 10.3969/j.issn.1006-0111.2018.06.005
    [15] 张金宇, 王丽红, 秦玉璘, 张璐璐, 姜远英, 曹永兵.  转录因子Cup2对白念珠菌铜离子代谢、氧化应激调控作用的初步研究 . 药学实践与服务, 2017, 35(3): 224-228. doi: 10.3969/j.issn.1006-0111.2017.03.008
    [16] 董雅芬, 舒菁菁, 马靖, 李菲, 彭程, 金磊, 谢和辉, 张川.  天然药物及其活性成分保护内皮祖细胞机制的研究进展 . 药学实践与服务, 2013, 31(1): 11-13,31. doi: 10.3969/j.issn.1006-0111.2013.01.003
    [17] 陈迁, 陈孟莉, 叶兆波.  五子衍宗复方总多糖对慢性酒精中毒大鼠肝脏的保护作用 . 药学实践与服务, 2012, 30(1): 25-28,31. doi: 10.3969/j.issn.1006-0111.2012.01.006
    [18] 周恒, 林焕冰, 卓烨烨, 毕炳添, 李国熊, 徐江平.  葡萄籽原花青素对血管性痴呆大鼠空间学习记忆能力的影响 . 药学实践与服务, 2011, 29(3): 208-211.
    [19] 刘厚淳, 陈万生.  何首乌水溶性成分2,3,5,4'-四羟基二苯乙烯-2-O-β-D葡萄糖苷的体外抗氧化作用研究 . 药学实践与服务, 2000, (4): 232-233,237.
    [20] A.T.Diplock.  抗氧化剂在临床上的实际应用 . 药学实践与服务, 1991, (3): 57-59.
  • 加载中
计量
  • 文章访问数:  3406
  • HTML全文浏览量:  392
  • PDF下载量:  95
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-11-28
  • 修回日期:  2014-03-26

线粒体靶向抗氧化剂研究进展

doi: 10.3969/j.issn.1006-0111.2015.01.001
    基金项目:  国家自然科学基金资助项目(81202458);全军医药卫生科研项目(CLZ12JB06)

摘要: 线粒体是细胞呼吸的主要场所,在细胞的生命周期中扮演重要角色,三羧酸循环和氧化磷酸化都是在线粒体中进行。线粒体功能障碍可导致一系列疾病,如缺血-再灌注损伤、败血症和糖尿病等。线粒体是神经退行性病变的治疗靶点,也是药物转运策略研究的引人注目的靶位。虽然线粒体所介导的疾病进程的分子机制尚未完全阐明,但氧化应激是关键的环节。开发线粒体靶向的抗氧化应激保护药物具有诱人的前景。线粒体靶向抗氧化剂是指以线粒体为作用靶位的具有抗氧化作用的药物。该文介绍了现有的线粒体靶向抗氧化剂的概念、分类及其疾病治疗研究进展。

English Abstract

樊鹏程, 葛越, 蒋炜, 景临林, 马慧萍, 贾正平. 线粒体靶向抗氧化剂研究进展[J]. 药学实践与服务, 2015, 33(1): 1-4,8. doi: 10.3969/j.issn.1006-0111.2015.01.001
引用本文: 樊鹏程, 葛越, 蒋炜, 景临林, 马慧萍, 贾正平. 线粒体靶向抗氧化剂研究进展[J]. 药学实践与服务, 2015, 33(1): 1-4,8. doi: 10.3969/j.issn.1006-0111.2015.01.001
FAN Pengcheng, GE Yue, Jiang Wei, JING Linlin, MA Huiping, JIA Zhengping. Research progress in mitochondria-targeted antioxidants[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 1-4,8. doi: 10.3969/j.issn.1006-0111.2015.01.001
Citation: FAN Pengcheng, GE Yue, Jiang Wei, JING Linlin, MA Huiping, JIA Zhengping. Research progress in mitochondria-targeted antioxidants[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 1-4,8. doi: 10.3969/j.issn.1006-0111.2015.01.001
参考文献 (33)

目录

    /

    返回文章
    返回